FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

His mother, Amberlie Reinertsen, says Mason has had lung complications since birth but has never been this sick before.

As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...

Vulnerable and elderly Australians are missing out on protection against respiratory syncytial virus (RSV) because many can’t ...

Pfizer said it will 'support capacity-building initiatives, such as training healthcare professionals and advancing clinical ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...

Vaccinating pregnant women against RSV reduced the risk of infection in their infants by 61% compared with newborns with ...

The article " After a Reset Year, Is Moderna Stock Poised for a Comeback? " first appeared on MarketBeat.

RSV is a contagious virus causing severe respiratory infections in infants. Vaccination during pregnancy, provides newborns ...

Expectant mothers will have access to free vaccines against respiratory syncytial virus (RSV) from next month under a major ...